Rezolute to participate in the jefferies global healthcare conference

Redwood city, calif., may 30, 2024 (globe newswire) -- rezolute, inc. (nasdaq: rzlt) (“rezolute” or the “company”), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced that nevan charles elam, chief executive officer and founder of rezolute, will participate in a fireside chat during the jefferies global healthcare conference on thursday, june 6, 2024, at 1:00 p.m. et in new york city.
RZLT Ratings Summary
RZLT Quant Ranking